Glomerular disease: Predicting outcomes in idiopathic membranous nephropathy

Nature Reviews Nephrology

Volumn 8, Issue 9, 2012, Pages 496-498

  Praga, Manuel ^a   Rojas Rivera, Jorge ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BIOLOGICAL MARKER; CALCINEURIN INHIBITOR; CORTICOSTEROID; DIURETIC AGENT; PHOSPHOLIPASE A2 RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

DIET RESTRICTION; DIURETIC THERAPY; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC MEMBRANOUS NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; REMISSION; REVIEW; SCORING SYSTEM;

BIOLOGICAL MARKERS; COHORT STUDIES; COMBINED MODALITY THERAPY; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEINURIA; REMISSION, SPONTANEOUS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 84865488454     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2012.161     Document Type: Review

References (10)

1. Fervenza, F. C., Sethi, S. & Specks, U. Idiopathic membranous nephropathy: diagnosis and treatment. Clin. J. Am. Soc. Nephrol. 3, 905-919 (2008
2. van den Brand, J. A., Hofstra, J. M. & Wetzels, J. F. Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol. http://dx.doi.org/10.2215/CJN.00670112.
3. Polanco, N. et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J. Am. Soc. Nephrol. 21, 697-704 (2010
4. Cattran, D. C. et al. Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int. 51, 901-907 (1997
5. Branten, A. J. et al. Urinary excretion of β2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: A validation study. J. Am. Soc. Nephrol. 16, 169-174 (2005
6. du Buf-Vereijken, P. W., Branten, A. J. & Wetzels, J. F. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy. Am. J. Kidney Dis. 46, 1012-1029 (2005
7. van den Brand, J. A., Hofstra, J. M. & Wetzels, J. F. Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol. 6, 2846-2853 (2011
8. Beck, L. H. Jr & Salant, D. J. Membranous nephropathy: recent travels and new roads ahead. Kidney Int. 77, 765-770 (2010
9. Hofstra, J. M., Beck, L. H. Jr, Beck, D. M., Wetzels, J. F. & Salant, D. J. Antiphospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol. 6, 1286-1291 (2011
10. Beck, L. H. Jr et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J. Am. Soc. Nephrol. 22, 1543-1550 (2011).